BioLine Rx Ltd

BLRXNASDAQ
$2.67
-0.02-0.74%
At close: Sep 4, 5:00 PM EST
$2.51
-0.16-5.98%
After Hours: Sep 4, 4:35 PM EST
Earnings: Q2 2026 Earnings were released on Mon Aug 31st, before the market open
Conference Call: The most recent conference call started at 8:30 AM, 6 days ago
Click to view the webcast

BioLine Rx Analyst Price Targets

Wall Street analyst price targets and consensus rating for BioLine Rx (BLRX).

Price Target Range — 8 Quarters

Analyst Consensus — 2 Analysts

2Buy
Consensus RatingBuy# Analysts2Avg. Consensus PT$19Upside to Avg. PT+656.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings
DateFirmAnalystActionRating ChangePrice Target
Jun 17, 2025HC Wainwright & Co.Joseph PantginisMaintainedBuy$26
May 30, 2025Jones TradingJustin WalshUpgradeHoldBuy$12